Advertisement

Index by author

May 01, 2011; Volume 39,Issue 5

A

  1. Adachi, Yasuhisa

    1. Organic Anion Transporter 3 Mediates the Efflux Transport of an Amphipathic Organic Anion, Dehydroepiandrosterone Sulfate, across the Blood-Brain Barrier in Mice
      Mari Miyajima, Hiroyuki Kusuhara, Miki Fujishima, Yasuhisa Adachi and Yuichi Sugiyama
      Drug Metabolism and Disposition May 2011, 39 (5) 814-819; DOI: https://doi.org/10.1124/dmd.110.036863

  2. Akiyama, Yuko

    1. Sorafenib and Sunitinib, Two Anticancer Drugs, Inhibit CYP3A4-Mediated and Activate CY3A5-Mediated Midazolam 1′-Hydroxylation
      Minako Sugiyama, Ken-ichi Fujita, Norie Murayama, Yuko Akiyama, Hiroshi Yamazaki and Yasutsuna Sasaki
      Drug Metabolism and Disposition May 2011, 39 (5) 757-762; DOI: https://doi.org/10.1124/dmd.110.037853

  3. Allentoff, Alban

    1. Metabolism and Disposition of [14C]Brivanib Alaninate after Oral Administration to Rats, Monkeys, and Humans
      Jiachang Gong, Jinping Gan, Janet Caceres-Cortes, Lisa J. Christopher, Vinod Arora, Eric Masson, Daphne Williams, Janice Pursley, Alban Allentoff, Michael Lago, Scott B. Tran and Ramaswamy A. Iyer
      Drug Metabolism and Disposition May 2011, 39 (5) 891-903; DOI: https://doi.org/10.1124/dmd.110.037341

  4. An, Nianzhen

    1. Evaluation of the Effects of 20 Nonsynonymous Single Nucleotide Polymorphisms of CYP2C19 on S-Mephenytoin 4′-Hydroxylation and Omeprazole 5′-Hydroxylation
      Huijuan Wang, Nianzhen An, Hao Wang, Yiwen Gao, Duan Liu, Ting Bian, Juanli Zhu and Chao Chen
      Drug Metabolism and Disposition May 2011, 39 (5) 830-837; DOI: https://doi.org/10.1124/dmd.110.037549

  5. Andersson, Marine L.

    1. Seasonal Variation in Blood Drug Concentrations and a Potential Relationship to Vitamin D
      Jonatan D. Lindh, Marine L. Andersson, Erik Eliasson and Linda Björkhem-Bergman
      Drug Metabolism and Disposition May 2011, 39 (5) 933-937; DOI: https://doi.org/10.1124/dmd.111.038125

  6. Arora, Vinod

    1. Metabolism and Disposition of [14C]Brivanib Alaninate after Oral Administration to Rats, Monkeys, and Humans
      Jiachang Gong, Jinping Gan, Janet Caceres-Cortes, Lisa J. Christopher, Vinod Arora, Eric Masson, Daphne Williams, Janice Pursley, Alban Allentoff, Michael Lago, Scott B. Tran and Ramaswamy A. Iyer
      Drug Metabolism and Disposition May 2011, 39 (5) 891-903; DOI: https://doi.org/10.1124/dmd.110.037341

B

  1. Backman, Janne T.

    1. Reevaluation of the Microsomal Metabolism of Montelukast: Major Contribution by CYP2C8 at Clinically Relevant Concentrations
      Anne M. Filppula, Jouko Laitila, Pertti J. Neuvonen and Janne T. Backman
      Drug Metabolism and Disposition May 2011, 39 (5) 904-911; DOI: https://doi.org/10.1124/dmd.110.037689

  2. Balogh, Larissa

    1. Pharmacokinetic Interaction of the Antiparasitic Agents Ivermectin and Spinosad in Dogs
      Stewart T. Dunn, Laura Hedges, Kathleen E. Sampson, Yurong Lai, Sean Mahabir, Larissa Balogh and Charles W. Locuson
      Drug Metabolism and Disposition May 2011, 39 (5) 789-795; DOI: https://doi.org/10.1124/dmd.110.034827

  3. Bao, Narisu

    1. Contribution of Carboxylesterase in Hamster to the Intestinal First-Pass Loss and Low Bioavailability of Ethyl Piperate, an Effective Lipid-Lowering Drug Candidate
      Youli Lu, Narisu Bao, Gereltu Borjihan, Yanling Ma, Miaomiao Hu, Chen Yu, Shuijun Li, Jingying Jia, Ding Yang and Yiping Wang
      Drug Metabolism and Disposition May 2011, 39 (5) 796-802; DOI: https://doi.org/10.1124/dmd.110.037614

  4. Barbuch, Robert J.

    1. Metabolism of LY654322, a Growth Hormone Secretagogue, to an Unusual Diimidazopyridine Metabolite
      Anthony G. Borel, Timothy M. Jones, Robert J. Barbuch, David A. Jackson, Palaniappan Kulanthaivel, Edward Mattiuz, Valentine J. Klimkowski, William J. Wheeler and Gregory A. Rener
      Drug Metabolism and Disposition May 2011, 39 (5) 740-749; DOI: https://doi.org/10.1124/dmd.110.037598

  5. Bast, Aalt

    1. Identification of the Metabolites of the Antioxidant Flavonoid 7-Mono-O-(β-hydroxyethyl)-rutoside in Mice
      Hilde Jacobs, Ron Peters, Gertjan J. M. den Hartog, Wim J. F. van der Vijgh, Aalt Bast and Guido R. M. M. Haenen
      Drug Metabolism and Disposition May 2011, 39 (5) 750-756; DOI: https://doi.org/10.1124/dmd.110.036525

  6. Bateman, Kevin

    1. Novel Cytochrome P450-Mediated Ring Opening of the 1,3,4-Oxadiazole in Setileuton, a 5-Lipoxygenase Inhibitor
      Cheri M. Maciolek, Bennett Ma, Karsten Menzel, Sebastien Laliberte, Kevin Bateman, Paul Krolikowski and Christoper R. Gibson
      Drug Metabolism and Disposition May 2011, 39 (5) 763-770; DOI: https://doi.org/10.1124/dmd.110.037366

  7. Beijnen, Jos H.

    1. Differential Impact of P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) on Axitinib Brain Accumulation and Oral Plasma Pharmacokinetics
      Birk Poller, Dilek Iusuf, Rolf W. Sparidans, Els Wagenaar, Jos H. Beijnen and Alfred H. Schinkel
      Drug Metabolism and Disposition May 2011, 39 (5) 729-735; DOI: https://doi.org/10.1124/dmd.110.037317

  8. Bian, Ting

    1. Evaluation of the Effects of 20 Nonsynonymous Single Nucleotide Polymorphisms of CYP2C19 on S-Mephenytoin 4′-Hydroxylation and Omeprazole 5′-Hydroxylation
      Huijuan Wang, Nianzhen An, Hao Wang, Yiwen Gao, Duan Liu, Ting Bian, Juanli Zhu and Chao Chen
      Drug Metabolism and Disposition May 2011, 39 (5) 830-837; DOI: https://doi.org/10.1124/dmd.110.037549

  9. Björkhem-Bergman, Linda

    1. Seasonal Variation in Blood Drug Concentrations and a Potential Relationship to Vitamin D
      Jonatan D. Lindh, Marine L. Andersson, Erik Eliasson and Linda Björkhem-Bergman
      Drug Metabolism and Disposition May 2011, 39 (5) 933-937; DOI: https://doi.org/10.1124/dmd.111.038125

  10. Bondesson, Ulf

    1. In Vivo Investigation in Pigs of Intestinal Absorption, Hepatobiliary Disposition, and Metabolism of the 5α-Reductase Inhibitor Finasteride and the Effects of Coadministered Ketoconazole
      Anna Lundahl, Mikael Hedeland, Ulf Bondesson and Hans Lennernäs
      Drug Metabolism and Disposition May 2011, 39 (5) 847-857; DOI: https://doi.org/10.1124/dmd.110.035311

  11. Borel, Anthony G.

    1. Metabolism of LY654322, a Growth Hormone Secretagogue, to an Unusual Diimidazopyridine Metabolite
      Anthony G. Borel, Timothy M. Jones, Robert J. Barbuch, David A. Jackson, Palaniappan Kulanthaivel, Edward Mattiuz, Valentine J. Klimkowski, William J. Wheeler and Gregory A. Rener
      Drug Metabolism and Disposition May 2011, 39 (5) 740-749; DOI: https://doi.org/10.1124/dmd.110.037598

  12. Borjihan, Gereltu

    1. Contribution of Carboxylesterase in Hamster to the Intestinal First-Pass Loss and Low Bioavailability of Ethyl Piperate, an Effective Lipid-Lowering Drug Candidate
      Youli Lu, Narisu Bao, Gereltu Borjihan, Yanling Ma, Miaomiao Hu, Chen Yu, Shuijun Li, Jingying Jia, Ding Yang and Yiping Wang
      Drug Metabolism and Disposition May 2011, 39 (5) 796-802; DOI: https://doi.org/10.1124/dmd.110.037614

  13. Bredberg, Ulf

    1. Optimal Experimental Design for Assessment of Enzyme Kinetics in a Drug Discovery Screening Environment
      Erik Sjögren, Joakim Nyberg, Mats O. Magnusson, Hans Lennernäs, Andrew Hooker and Ulf Bredberg
      Drug Metabolism and Disposition May 2011, 39 (5) 858-863; DOI: https://doi.org/10.1124/dmd.110.037309

  14. Brenneman, Debbie

    1. Liver-Selective Expression of Human Arylamine N-Acetyltransferase NAT2 in Transgenic Mice
      Kim S. Sugamori, Debbie Brenneman and Denis M. Grant
      Drug Metabolism and Disposition May 2011, 39 (5) 882-890; DOI: https://doi.org/10.1124/dmd.111.038216

C

  1. Caceres-Cortes, Janet

    1. Metabolism and Disposition of [14C]Brivanib Alaninate after Oral Administration to Rats, Monkeys, and Humans
      Jiachang Gong, Jinping Gan, Janet Caceres-Cortes, Lisa J. Christopher, Vinod Arora, Eric Masson, Daphne Williams, Janice Pursley, Alban Allentoff, Michael Lago, Scott B. Tran and Ramaswamy A. Iyer
      Drug Metabolism and Disposition May 2011, 39 (5) 891-903; DOI: https://doi.org/10.1124/dmd.110.037341

  2. Chen, Chao

    1. Evaluation of the Effects of 20 Nonsynonymous Single Nucleotide Polymorphisms of CYP2C19 on S-Mephenytoin 4′-Hydroxylation and Omeprazole 5′-Hydroxylation
      Huijuan Wang, Nianzhen An, Hao Wang, Yiwen Gao, Duan Liu, Ting Bian, Juanli Zhu and Chao Chen
      Drug Metabolism and Disposition May 2011, 39 (5) 830-837; DOI: https://doi.org/10.1124/dmd.110.037549

  3. Cheng, Kunrong

    1. In Vivo Magnetic Resonance Imaging to Detect Biliary Excretion of 19F-Labeled Drug in Mice
      Jean-Pierre Raufman, Su Xu, Kunrong Cheng, Sandeep Khurana, Diana Johnson, Changxing Shao, Maureen A. Kane, Da Shi, Rao Gullapalli and James Polli
      Drug Metabolism and Disposition May 2011, 39 (5) 736-739; DOI: https://doi.org/10.1124/dmd.110.037358

  4. Christopher, Lisa J.

    1. Metabolism and Disposition of [14C]Brivanib Alaninate after Oral Administration to Rats, Monkeys, and Humans
      Jiachang Gong, Jinping Gan, Janet Caceres-Cortes, Lisa J. Christopher, Vinod Arora, Eric Masson, Daphne Williams, Janice Pursley, Alban Allentoff, Michael Lago, Scott B. Tran and Ramaswamy A. Iyer
      Drug Metabolism and Disposition May 2011, 39 (5) 891-903; DOI: https://doi.org/10.1124/dmd.110.037341

  5. Collier, Abby C.

    1. The Development of UDP-Glucuronosyltransferases 1A1 and 1A6 in the Pediatric Liver
      Shogo J. Miyagi and Abby C. Collier
      Drug Metabolism and Disposition May 2011, 39 (5) 912-919; DOI: https://doi.org/10.1124/dmd.110.037192

  6. Cubitt, Helen E.

    1. Prediction of Human Drug Clearance by Multiple Metabolic Pathways: Integration of Hepatic and Intestinal Microsomal and Cytosolic Data
      Helen E. Cubitt, J. Brian Houston and Aleksandra Galetin
      Drug Metabolism and Disposition May 2011, 39 (5) 864-873; DOI: https://doi.org/10.1124/dmd.110.036566

D

  1. Deguchi, Tsuneo

    1. Human Pharmacokinetic Prediction of UDP-Glucuronosyltransferase Substrates with an Animal Scale-Up Approach
      Tsuneo Deguchi, Nobuaki Watanabe, Atsushi Kurihara, Katsuhiro Igeta, Hidenori Ikenaga, Keiichi Fusegawa, Norio Suzuki, Shinji Murata, Masakazu Hirouchi, Yoshitake Furuta, Masaru Iwasaki, Osamu Okazaki and Takashi Izumi
      Drug Metabolism and Disposition May 2011, 39 (5) 820-829; DOI: https://doi.org/10.1124/dmd.110.037457

  2. den Hartog, Gertjan J. M.

    1. Identification of the Metabolites of the Antioxidant Flavonoid 7-Mono-O-(β-hydroxyethyl)-rutoside in Mice
      Hilde Jacobs, Ron Peters, Gertjan J. M. den Hartog, Wim J. F. van der Vijgh, Aalt Bast and Guido R. M. M. Haenen
      Drug Metabolism and Disposition May 2011, 39 (5) 750-756; DOI: https://doi.org/10.1124/dmd.110.036525

  3. Doroshyenko, Oxana

    1. Effect of the CYP2C8 Genotype on the Pharmacokinetics and Pharmacodynamics of Repaglinide
      Dorota Tomalik-Scharte, Uwe Fuhr, Martin Hellmich, Dorothee Frank, Oxana Doroshyenko, Alexander Jetter and Julia C. Stingl
      Drug Metabolism and Disposition May 2011, 39 (5) 927-932; DOI: https://doi.org/10.1124/dmd.110.036921

  4. Dunn, Stewart T.

    1. Pharmacokinetic Interaction of the Antiparasitic Agents Ivermectin and Spinosad in Dogs
      Stewart T. Dunn, Laura Hedges, Kathleen E. Sampson, Yurong Lai, Sean Mahabir, Larissa Balogh and Charles W. Locuson
      Drug Metabolism and Disposition May 2011, 39 (5) 789-795; DOI: https://doi.org/10.1124/dmd.110.034827

E

  1. Eliasson, Erik

    1. Seasonal Variation in Blood Drug Concentrations and a Potential Relationship to Vitamin D
      Jonatan D. Lindh, Marine L. Andersson, Erik Eliasson and Linda Björkhem-Bergman
      Drug Metabolism and Disposition May 2011, 39 (5) 933-937; DOI: https://doi.org/10.1124/dmd.111.038125

F

  1. Filppula, Anne M.

    1. Reevaluation of the Microsomal Metabolism of Montelukast: Major Contribution by CYP2C8 at Clinically Relevant Concentrations
      Anne M. Filppula, Jouko Laitila, Pertti J. Neuvonen and Janne T. Backman
      Drug Metabolism and Disposition May 2011, 39 (5) 904-911; DOI: https://doi.org/10.1124/dmd.110.037689

  2. Frank, Dorothee

    1. Effect of the CYP2C8 Genotype on the Pharmacokinetics and Pharmacodynamics of Repaglinide
      Dorota Tomalik-Scharte, Uwe Fuhr, Martin Hellmich, Dorothee Frank, Oxana Doroshyenko, Alexander Jetter and Julia C. Stingl
      Drug Metabolism and Disposition May 2011, 39 (5) 927-932; DOI: https://doi.org/10.1124/dmd.110.036921

  3. Fuhr, Uwe

    1. Effect of the CYP2C8 Genotype on the Pharmacokinetics and Pharmacodynamics of Repaglinide
      Dorota Tomalik-Scharte, Uwe Fuhr, Martin Hellmich, Dorothee Frank, Oxana Doroshyenko, Alexander Jetter and Julia C. Stingl
      Drug Metabolism and Disposition May 2011, 39 (5) 927-932; DOI: https://doi.org/10.1124/dmd.110.036921

  4. Fujishima, Miki

    1. Organic Anion Transporter 3 Mediates the Efflux Transport of an Amphipathic Organic Anion, Dehydroepiandrosterone Sulfate, across the Blood-Brain Barrier in Mice
      Mari Miyajima, Hiroyuki Kusuhara, Miki Fujishima, Yasuhisa Adachi and Yuichi Sugiyama
      Drug Metabolism and Disposition May 2011, 39 (5) 814-819; DOI: https://doi.org/10.1124/dmd.110.036863

  5. Fujita, Ken-ichi

    1. Sorafenib and Sunitinib, Two Anticancer Drugs, Inhibit CYP3A4-Mediated and Activate CY3A5-Mediated Midazolam 1′-Hydroxylation
      Minako Sugiyama, Ken-ichi Fujita, Norie Murayama, Yuko Akiyama, Hiroshi Yamazaki and Yasutsuna Sasaki
      Drug Metabolism and Disposition May 2011, 39 (5) 757-762; DOI: https://doi.org/10.1124/dmd.110.037853

  6. Fukami, Tatsuki

    1. CYP2C9-Mediated Metabolic Activation of Losartan Detected by a Highly Sensitive Cell-Based Screening Assay
      Atsushi Iwamura, Tatsuki Fukami, Hiroko Hosomi, Miki Nakajima and Tsuyoshi Yokoi
      Drug Metabolism and Disposition May 2011, 39 (5) 838-846; DOI: https://doi.org/10.1124/dmd.110.037259

  7. Fukumoto, Hiroyuki

    1. Metabolism of the c-Fos/Activator Protein-1 Inhibitor T-5224 by Multiple Human UDP-Glucuronosyltransferase Isoforms
      Shinsuke Uchihashi, Hiroyuki Fukumoto, Makoto Onoda, Hiroyoshi Hayakawa, Shin-ichi Ikushiro and Toshiyuki Sakaki
      Drug Metabolism and Disposition May 2011, 39 (5) 803-813; DOI: https://doi.org/10.1124/dmd.110.037952

  8. Furuta, Yoshitake

    1. Human Pharmacokinetic Prediction of UDP-Glucuronosyltransferase Substrates with an Animal Scale-Up Approach
      Tsuneo Deguchi, Nobuaki Watanabe, Atsushi Kurihara, Katsuhiro Igeta, Hidenori Ikenaga, Keiichi Fusegawa, Norio Suzuki, Shinji Murata, Masakazu Hirouchi, Yoshitake Furuta, Masaru Iwasaki, Osamu Okazaki and Takashi Izumi
      Drug Metabolism and Disposition May 2011, 39 (5) 820-829; DOI: https://doi.org/10.1124/dmd.110.037457

  9. Fusegawa, Keiichi

    1. Human Pharmacokinetic Prediction of UDP-Glucuronosyltransferase Substrates with an Animal Scale-Up Approach
      Tsuneo Deguchi, Nobuaki Watanabe, Atsushi Kurihara, Katsuhiro Igeta, Hidenori Ikenaga, Keiichi Fusegawa, Norio Suzuki, Shinji Murata, Masakazu Hirouchi, Yoshitake Furuta, Masaru Iwasaki, Osamu Okazaki and Takashi Izumi
      Drug Metabolism and Disposition May 2011, 39 (5) 820-829; DOI: https://doi.org/10.1124/dmd.110.037457

G

  1. Galetin, Aleksandra

    1. Prediction of Human Drug Clearance by Multiple Metabolic Pathways: Integration of Hepatic and Intestinal Microsomal and Cytosolic Data
      Helen E. Cubitt, J. Brian Houston and Aleksandra Galetin
      Drug Metabolism and Disposition May 2011, 39 (5) 864-873; DOI: https://doi.org/10.1124/dmd.110.036566

  2. Gan, Jinping

    1. Metabolism and Disposition of [14C]Brivanib Alaninate after Oral Administration to Rats, Monkeys, and Humans
      Jiachang Gong, Jinping Gan, Janet Caceres-Cortes, Lisa J. Christopher, Vinod Arora, Eric Masson, Daphne Williams, Janice Pursley, Alban Allentoff, Michael Lago, Scott B. Tran and Ramaswamy A. Iyer
      Drug Metabolism and Disposition May 2011, 39 (5) 891-903; DOI: https://doi.org/10.1124/dmd.110.037341

  3. Gandhi, Adarsh

    1. Differential Role of Toll-Interleukin 1 Receptor Domain-Containing Adaptor Protein in Toll-Like Receptor 2-Mediated Regulation of Gene Expression of Hepatic Cytokines and Drug-Metabolizing Enzymes
      Romi Ghose, Tao Guo, Jesus G. Vallejo and Adarsh Gandhi
      Drug Metabolism and Disposition May 2011, 39 (5) 874-881; DOI: https://doi.org/10.1124/dmd.110.037382

  4. Gao, Yiwen

    1. Evaluation of the Effects of 20 Nonsynonymous Single Nucleotide Polymorphisms of CYP2C19 on S-Mephenytoin 4′-Hydroxylation and Omeprazole 5′-Hydroxylation
      Huijuan Wang, Nianzhen An, Hao Wang, Yiwen Gao, Duan Liu, Ting Bian, Juanli Zhu and Chao Chen
      Drug Metabolism and Disposition May 2011, 39 (5) 830-837; DOI: https://doi.org/10.1124/dmd.110.037549

  5. Ghose, Romi

    1. Differential Role of Toll-Interleukin 1 Receptor Domain-Containing Adaptor Protein in Toll-Like Receptor 2-Mediated Regulation of Gene Expression of Hepatic Cytokines and Drug-Metabolizing Enzymes
      Romi Ghose, Tao Guo, Jesus G. Vallejo and Adarsh Gandhi
      Drug Metabolism and Disposition May 2011, 39 (5) 874-881; DOI: https://doi.org/10.1124/dmd.110.037382

  6. Gibson, Christoper R.

    1. Novel Cytochrome P450-Mediated Ring Opening of the 1,3,4-Oxadiazole in Setileuton, a 5-Lipoxygenase Inhibitor
      Cheri M. Maciolek, Bennett Ma, Karsten Menzel, Sebastien Laliberte, Kevin Bateman, Paul Krolikowski and Christoper R. Gibson
      Drug Metabolism and Disposition May 2011, 39 (5) 763-770; DOI: https://doi.org/10.1124/dmd.110.037366

  7. Gong, Jiachang

    1. Metabolism and Disposition of [14C]Brivanib Alaninate after Oral Administration to Rats, Monkeys, and Humans
      Jiachang Gong, Jinping Gan, Janet Caceres-Cortes, Lisa J. Christopher, Vinod Arora, Eric Masson, Daphne Williams, Janice Pursley, Alban Allentoff, Michael Lago, Scott B. Tran and Ramaswamy A. Iyer
      Drug Metabolism and Disposition May 2011, 39 (5) 891-903; DOI: https://doi.org/10.1124/dmd.110.037341

  8. Grant, Denis M.

    1. Liver-Selective Expression of Human Arylamine N-Acetyltransferase NAT2 in Transgenic Mice
      Kim S. Sugamori, Debbie Brenneman and Denis M. Grant
      Drug Metabolism and Disposition May 2011, 39 (5) 882-890; DOI: https://doi.org/10.1124/dmd.111.038216

  9. Gullapalli, Rao

    1. In Vivo Magnetic Resonance Imaging to Detect Biliary Excretion of 19F-Labeled Drug in Mice
      Jean-Pierre Raufman, Su Xu, Kunrong Cheng, Sandeep Khurana, Diana Johnson, Changxing Shao, Maureen A. Kane, Da Shi, Rao Gullapalli and James Polli
      Drug Metabolism and Disposition May 2011, 39 (5) 736-739; DOI: https://doi.org/10.1124/dmd.110.037358

  10. Guo, Tao

    1. Differential Role of Toll-Interleukin 1 Receptor Domain-Containing Adaptor Protein in Toll-Like Receptor 2-Mediated Regulation of Gene Expression of Hepatic Cytokines and Drug-Metabolizing Enzymes
      Romi Ghose, Tao Guo, Jesus G. Vallejo and Adarsh Gandhi
      Drug Metabolism and Disposition May 2011, 39 (5) 874-881; DOI: https://doi.org/10.1124/dmd.110.037382

H

  1. Haenen, Guido R. M. M.

    1. Identification of the Metabolites of the Antioxidant Flavonoid 7-Mono-O-(β-hydroxyethyl)-rutoside in Mice
      Hilde Jacobs, Ron Peters, Gertjan J. M. den Hartog, Wim J. F. van der Vijgh, Aalt Bast and Guido R. M. M. Haenen
      Drug Metabolism and Disposition May 2011, 39 (5) 750-756; DOI: https://doi.org/10.1124/dmd.110.036525

  2. Hagenbuch, Bruno

    1. Interactions of Green Tea Catechins with Organic Anion-Transporting Polypeptides
      Megan Roth, Barbara N. Timmermann and Bruno Hagenbuch
      Drug Metabolism and Disposition May 2011, 39 (5) 920-926; DOI: https://doi.org/10.1124/dmd.110.036640

  3. Hayakawa, Hiroyoshi

    1. Metabolism of the c-Fos/Activator Protein-1 Inhibitor T-5224 by Multiple Human UDP-Glucuronosyltransferase Isoforms
      Shinsuke Uchihashi, Hiroyuki Fukumoto, Makoto Onoda, Hiroyoshi Hayakawa, Shin-ichi Ikushiro and Toshiyuki Sakaki
      Drug Metabolism and Disposition May 2011, 39 (5) 803-813; DOI: https://doi.org/10.1124/dmd.110.037952

  4. Hedeland, Mikael

    1. In Vivo Investigation in Pigs of Intestinal Absorption, Hepatobiliary Disposition, and Metabolism of the 5α-Reductase Inhibitor Finasteride and the Effects of Coadministered Ketoconazole
      Anna Lundahl, Mikael Hedeland, Ulf Bondesson and Hans Lennernäs
      Drug Metabolism and Disposition May 2011, 39 (5) 847-857; DOI: https://doi.org/10.1124/dmd.110.035311

  5. Hedges, Laura

    1. Pharmacokinetic Interaction of the Antiparasitic Agents Ivermectin and Spinosad in Dogs
      Stewart T. Dunn, Laura Hedges, Kathleen E. Sampson, Yurong Lai, Sean Mahabir, Larissa Balogh and Charles W. Locuson
      Drug Metabolism and Disposition May 2011, 39 (5) 789-795; DOI: https://doi.org/10.1124/dmd.110.034827

  6. Hellmich, Martin

    1. Effect of the CYP2C8 Genotype on the Pharmacokinetics and Pharmacodynamics of Repaglinide
      Dorota Tomalik-Scharte, Uwe Fuhr, Martin Hellmich, Dorothee Frank, Oxana Doroshyenko, Alexander Jetter and Julia C. Stingl
      Drug Metabolism and Disposition May 2011, 39 (5) 927-932; DOI: https://doi.org/10.1124/dmd.110.036921

  7. Hirouchi, Masakazu

    1. Human Pharmacokinetic Prediction of UDP-Glucuronosyltransferase Substrates with an Animal Scale-Up Approach
      Tsuneo Deguchi, Nobuaki Watanabe, Atsushi Kurihara, Katsuhiro Igeta, Hidenori Ikenaga, Keiichi Fusegawa, Norio Suzuki, Shinji Murata, Masakazu Hirouchi, Yoshitake Furuta, Masaru Iwasaki, Osamu Okazaki and Takashi Izumi
      Drug Metabolism and Disposition May 2011, 39 (5) 820-829; DOI: https://doi.org/10.1124/dmd.110.037457

  8. Hollenberg, Paul F.

    1. Anandamide Oxidation by Wild-Type and Polymorphically Expressed CYP2B6 and CYP2D6
      Chitra Sridar, Natasha T. Snider and Paul F. Hollenberg
      Drug Metabolism and Disposition May 2011, 39 (5) 782-788; DOI: https://doi.org/10.1124/dmd.110.036707

  9. Hooker, Andrew

    1. Optimal Experimental Design for Assessment of Enzyme Kinetics in a Drug Discovery Screening Environment
      Erik Sjögren, Joakim Nyberg, Mats O. Magnusson, Hans Lennernäs, Andrew Hooker and Ulf Bredberg
      Drug Metabolism and Disposition May 2011, 39 (5) 858-863; DOI: https://doi.org/10.1124/dmd.110.037309

  10. Hosomi, Hiroko

    1. CYP2C9-Mediated Metabolic Activation of Losartan Detected by a Highly Sensitive Cell-Based Screening Assay
      Atsushi Iwamura, Tatsuki Fukami, Hiroko Hosomi, Miki Nakajima and Tsuyoshi Yokoi
      Drug Metabolism and Disposition May 2011, 39 (5) 838-846; DOI: https://doi.org/10.1124/dmd.110.037259

  11. Houston, J. Brian

    1. Prediction of Human Drug Clearance by Multiple Metabolic Pathways: Integration of Hepatic and Intestinal Microsomal and Cytosolic Data
      Helen E. Cubitt, J. Brian Houston and Aleksandra Galetin
      Drug Metabolism and Disposition May 2011, 39 (5) 864-873; DOI: https://doi.org/10.1124/dmd.110.036566

  12. Hu, Miaomiao

    1. Contribution of Carboxylesterase in Hamster to the Intestinal First-Pass Loss and Low Bioavailability of Ethyl Piperate, an Effective Lipid-Lowering Drug Candidate
      Youli Lu, Narisu Bao, Gereltu Borjihan, Yanling Ma, Miaomiao Hu, Chen Yu, Shuijun Li, Jingying Jia, Ding Yang and Yiping Wang
      Drug Metabolism and Disposition May 2011, 39 (5) 796-802; DOI: https://doi.org/10.1124/dmd.110.037614

I

  1. Igeta, Katsuhiro

    1. Human Pharmacokinetic Prediction of UDP-Glucuronosyltransferase Substrates with an Animal Scale-Up Approach
      Tsuneo Deguchi, Nobuaki Watanabe, Atsushi Kurihara, Katsuhiro Igeta, Hidenori Ikenaga, Keiichi Fusegawa, Norio Suzuki, Shinji Murata, Masakazu Hirouchi, Yoshitake Furuta, Masaru Iwasaki, Osamu Okazaki and Takashi Izumi
      Drug Metabolism and Disposition May 2011, 39 (5) 820-829; DOI: https://doi.org/10.1124/dmd.110.037457

  2. Ikenaga, Hidenori

    1. Human Pharmacokinetic Prediction of UDP-Glucuronosyltransferase Substrates with an Animal Scale-Up Approach
      Tsuneo Deguchi, Nobuaki Watanabe, Atsushi Kurihara, Katsuhiro Igeta, Hidenori Ikenaga, Keiichi Fusegawa, Norio Suzuki, Shinji Murata, Masakazu Hirouchi, Yoshitake Furuta, Masaru Iwasaki, Osamu Okazaki and Takashi Izumi
      Drug Metabolism and Disposition May 2011, 39 (5) 820-829; DOI: https://doi.org/10.1124/dmd.110.037457

  3. Ikushiro, Shin-ichi

    1. Metabolism of the c-Fos/Activator Protein-1 Inhibitor T-5224 by Multiple Human UDP-Glucuronosyltransferase Isoforms
      Shinsuke Uchihashi, Hiroyuki Fukumoto, Makoto Onoda, Hiroyoshi Hayakawa, Shin-ichi Ikushiro and Toshiyuki Sakaki
      Drug Metabolism and Disposition May 2011, 39 (5) 803-813; DOI: https://doi.org/10.1124/dmd.110.037952

  4. Iusuf, Dilek

    1. Differential Impact of P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) on Axitinib Brain Accumulation and Oral Plasma Pharmacokinetics
      Birk Poller, Dilek Iusuf, Rolf W. Sparidans, Els Wagenaar, Jos H. Beijnen and Alfred H. Schinkel
      Drug Metabolism and Disposition May 2011, 39 (5) 729-735; DOI: https://doi.org/10.1124/dmd.110.037317

  5. Iwamura, Atsushi

    1. CYP2C9-Mediated Metabolic Activation of Losartan Detected by a Highly Sensitive Cell-Based Screening Assay
      Atsushi Iwamura, Tatsuki Fukami, Hiroko Hosomi, Miki Nakajima and Tsuyoshi Yokoi
      Drug Metabolism and Disposition May 2011, 39 (5) 838-846; DOI: https://doi.org/10.1124/dmd.110.037259

  6. Iwasaki, Masaru

    1. Human Pharmacokinetic Prediction of UDP-Glucuronosyltransferase Substrates with an Animal Scale-Up Approach
      Tsuneo Deguchi, Nobuaki Watanabe, Atsushi Kurihara, Katsuhiro Igeta, Hidenori Ikenaga, Keiichi Fusegawa, Norio Suzuki, Shinji Murata, Masakazu Hirouchi, Yoshitake Furuta, Masaru Iwasaki, Osamu Okazaki and Takashi Izumi
      Drug Metabolism and Disposition May 2011, 39 (5) 820-829; DOI: https://doi.org/10.1124/dmd.110.037457

  7. Iyer, Ramaswamy A.

    1. Metabolism and Disposition of [14C]Brivanib Alaninate after Oral Administration to Rats, Monkeys, and Humans
      Jiachang Gong, Jinping Gan, Janet Caceres-Cortes, Lisa J. Christopher, Vinod Arora, Eric Masson, Daphne Williams, Janice Pursley, Alban Allentoff, Michael Lago, Scott B. Tran and Ramaswamy A. Iyer
      Drug Metabolism and Disposition May 2011, 39 (5) 891-903; DOI: https://doi.org/10.1124/dmd.110.037341

  8. Izumi, Takashi

    1. Human Pharmacokinetic Prediction of UDP-Glucuronosyltransferase Substrates with an Animal Scale-Up Approach
      Tsuneo Deguchi, Nobuaki Watanabe, Atsushi Kurihara, Katsuhiro Igeta, Hidenori Ikenaga, Keiichi Fusegawa, Norio Suzuki, Shinji Murata, Masakazu Hirouchi, Yoshitake Furuta, Masaru Iwasaki, Osamu Okazaki and Takashi Izumi
      Drug Metabolism and Disposition May 2011, 39 (5) 820-829; DOI: https://doi.org/10.1124/dmd.110.037457

J

  1. Jackson, David A.

    1. Metabolism of LY654322, a Growth Hormone Secretagogue, to an Unusual Diimidazopyridine Metabolite
      Anthony G. Borel, Timothy M. Jones, Robert J. Barbuch, David A. Jackson, Palaniappan Kulanthaivel, Edward Mattiuz, Valentine J. Klimkowski, William J. Wheeler and Gregory A. Rener
      Drug Metabolism and Disposition May 2011, 39 (5) 740-749; DOI: https://doi.org/10.1124/dmd.110.037598

  2. Jacobs, Hilde

    1. Identification of the Metabolites of the Antioxidant Flavonoid 7-Mono-O-(β-hydroxyethyl)-rutoside in Mice
      Hilde Jacobs, Ron Peters, Gertjan J. M. den Hartog, Wim J. F. van der Vijgh, Aalt Bast and Guido R. M. M. Haenen
      Drug Metabolism and Disposition May 2011, 39 (5) 750-756; DOI: https://doi.org/10.1124/dmd.110.036525

  3. Jetter, Alexander

    1. Effect of the CYP2C8 Genotype on the Pharmacokinetics and Pharmacodynamics of Repaglinide
      Dorota Tomalik-Scharte, Uwe Fuhr, Martin Hellmich, Dorothee Frank, Oxana Doroshyenko, Alexander Jetter and Julia C. Stingl
      Drug Metabolism and Disposition May 2011, 39 (5) 927-932; DOI: https://doi.org/10.1124/dmd.110.036921

  4. Jia, Jingying

    1. Contribution of Carboxylesterase in Hamster to the Intestinal First-Pass Loss and Low Bioavailability of Ethyl Piperate, an Effective Lipid-Lowering Drug Candidate
      Youli Lu, Narisu Bao, Gereltu Borjihan, Yanling Ma, Miaomiao Hu, Chen Yu, Shuijun Li, Jingying Jia, Ding Yang and Yiping Wang
      Drug Metabolism and Disposition May 2011, 39 (5) 796-802; DOI: https://doi.org/10.1124/dmd.110.037614

  5. Johnson, Diana

    1. In Vivo Magnetic Resonance Imaging to Detect Biliary Excretion of 19F-Labeled Drug in Mice
      Jean-Pierre Raufman, Su Xu, Kunrong Cheng, Sandeep Khurana, Diana Johnson, Changxing Shao, Maureen A. Kane, Da Shi, Rao Gullapalli and James Polli
      Drug Metabolism and Disposition May 2011, 39 (5) 736-739; DOI: https://doi.org/10.1124/dmd.110.037358

  6. Jones, Timothy M.

    1. Metabolism of LY654322, a Growth Hormone Secretagogue, to an Unusual Diimidazopyridine Metabolite
      Anthony G. Borel, Timothy M. Jones, Robert J. Barbuch, David A. Jackson, Palaniappan Kulanthaivel, Edward Mattiuz, Valentine J. Klimkowski, William J. Wheeler and Gregory A. Rener
      Drug Metabolism and Disposition May 2011, 39 (5) 740-749; DOI: https://doi.org/10.1124/dmd.110.037598

K

  1. Kadam, Rajendra S.

    1. Influence of Drug Solubility and Lipophilicity on Transscleral Retinal Delivery of Six Corticosteroids
      Ashish Thakur, Rajendra S. Kadam and Uday B. Kompella
      Drug Metabolism and Disposition May 2011, 39 (5) 771-781; DOI: https://doi.org/10.1124/dmd.110.037408

  2. Kane, Maureen A.

    1. In Vivo Magnetic Resonance Imaging to Detect Biliary Excretion of 19F-Labeled Drug in Mice
      Jean-Pierre Raufman, Su Xu, Kunrong Cheng, Sandeep Khurana, Diana Johnson, Changxing Shao, Maureen A. Kane, Da Shi, Rao Gullapalli and James Polli
      Drug Metabolism and Disposition May 2011, 39 (5) 736-739; DOI: https://doi.org/10.1124/dmd.110.037358

  3. Khurana, Sandeep

    1. In Vivo Magnetic Resonance Imaging to Detect Biliary Excretion of 19F-Labeled Drug in Mice
      Jean-Pierre Raufman, Su Xu, Kunrong Cheng, Sandeep Khurana, Diana Johnson, Changxing Shao, Maureen A. Kane, Da Shi, Rao Gullapalli and James Polli
      Drug Metabolism and Disposition May 2011, 39 (5) 736-739; DOI: https://doi.org/10.1124/dmd.110.037358

  4. Klimkowski, Valentine J.

    1. Metabolism of LY654322, a Growth Hormone Secretagogue, to an Unusual Diimidazopyridine Metabolite
      Anthony G. Borel, Timothy M. Jones, Robert J. Barbuch, David A. Jackson, Palaniappan Kulanthaivel, Edward Mattiuz, Valentine J. Klimkowski, William J. Wheeler and Gregory A. Rener
      Drug Metabolism and Disposition May 2011, 39 (5) 740-749; DOI: https://doi.org/10.1124/dmd.110.037598

  5. Kompella, Uday B.

    1. Influence of Drug Solubility and Lipophilicity on Transscleral Retinal Delivery of Six Corticosteroids
      Ashish Thakur, Rajendra S. Kadam and Uday B. Kompella
      Drug Metabolism and Disposition May 2011, 39 (5) 771-781; DOI: https://doi.org/10.1124/dmd.110.037408

  6. Krolikowski, Paul

    1. Novel Cytochrome P450-Mediated Ring Opening of the 1,3,4-Oxadiazole in Setileuton, a 5-Lipoxygenase Inhibitor
      Cheri M. Maciolek, Bennett Ma, Karsten Menzel, Sebastien Laliberte, Kevin Bateman, Paul Krolikowski and Christoper R. Gibson
      Drug Metabolism and Disposition May 2011, 39 (5) 763-770; DOI: https://doi.org/10.1124/dmd.110.037366

  7. Kulanthaivel, Palaniappan

    1. Metabolism of LY654322, a Growth Hormone Secretagogue, to an Unusual Diimidazopyridine Metabolite
      Anthony G. Borel, Timothy M. Jones, Robert J. Barbuch, David A. Jackson, Palaniappan Kulanthaivel, Edward Mattiuz, Valentine J. Klimkowski, William J. Wheeler and Gregory A. Rener
      Drug Metabolism and Disposition May 2011, 39 (5) 740-749; DOI: https://doi.org/10.1124/dmd.110.037598

  8. Kurihara, Atsushi

    1. Human Pharmacokinetic Prediction of UDP-Glucuronosyltransferase Substrates with an Animal Scale-Up Approach
      Tsuneo Deguchi, Nobuaki Watanabe, Atsushi Kurihara, Katsuhiro Igeta, Hidenori Ikenaga, Keiichi Fusegawa, Norio Suzuki, Shinji Murata, Masakazu Hirouchi, Yoshitake Furuta, Masaru Iwasaki, Osamu Okazaki and Takashi Izumi
      Drug Metabolism and Disposition May 2011, 39 (5) 820-829; DOI: https://doi.org/10.1124/dmd.110.037457

  9. Kusuhara, Hiroyuki

    1. Organic Anion Transporter 3 Mediates the Efflux Transport of an Amphipathic Organic Anion, Dehydroepiandrosterone Sulfate, across the Blood-Brain Barrier in Mice
      Mari Miyajima, Hiroyuki Kusuhara, Miki Fujishima, Yasuhisa Adachi and Yuichi Sugiyama
      Drug Metabolism and Disposition May 2011, 39 (5) 814-819; DOI: https://doi.org/10.1124/dmd.110.036863

L

  1. Lago, Michael

    1. Metabolism and Disposition of [14C]Brivanib Alaninate after Oral Administration to Rats, Monkeys, and Humans
      Jiachang Gong, Jinping Gan, Janet Caceres-Cortes, Lisa J. Christopher, Vinod Arora, Eric Masson, Daphne Williams, Janice Pursley, Alban Allentoff, Michael Lago, Scott B. Tran and Ramaswamy A. Iyer
      Drug Metabolism and Disposition May 2011, 39 (5) 891-903; DOI: https://doi.org/10.1124/dmd.110.037341

  2. Lai, Yurong

    1. Pharmacokinetic Interaction of the Antiparasitic Agents Ivermectin and Spinosad in Dogs
      Stewart T. Dunn, Laura Hedges, Kathleen E. Sampson, Yurong Lai, Sean Mahabir, Larissa Balogh and Charles W. Locuson
      Drug Metabolism and Disposition May 2011, 39 (5) 789-795; DOI: https://doi.org/10.1124/dmd.110.034827

  3. Laitila, Jouko

    1. Reevaluation of the Microsomal Metabolism of Montelukast: Major Contribution by CYP2C8 at Clinically Relevant Concentrations
      Anne M. Filppula, Jouko Laitila, Pertti J. Neuvonen and Janne T. Backman
      Drug Metabolism and Disposition May 2011, 39 (5) 904-911; DOI: https://doi.org/10.1124/dmd.110.037689

  4. Laliberte, Sebastien

    1. Novel Cytochrome P450-Mediated Ring Opening of the 1,3,4-Oxadiazole in Setileuton, a 5-Lipoxygenase Inhibitor
      Cheri M. Maciolek, Bennett Ma, Karsten Menzel, Sebastien Laliberte, Kevin Bateman, Paul Krolikowski and Christoper R. Gibson
      Drug Metabolism and Disposition May 2011, 39 (5) 763-770; DOI: https://doi.org/10.1124/dmd.110.037366

  5. Lennernäs, Hans

    1. In Vivo Investigation in Pigs of Intestinal Absorption, Hepatobiliary Disposition, and Metabolism of the 5α-Reductase Inhibitor Finasteride and the Effects of Coadministered Ketoconazole
      Anna Lundahl, Mikael Hedeland, Ulf Bondesson and Hans Lennernäs
      Drug Metabolism and Disposition May 2011, 39 (5) 847-857; DOI: https://doi.org/10.1124/dmd.110.035311
    2. Optimal Experimental Design for Assessment of Enzyme Kinetics in a Drug Discovery Screening Environment
      Erik Sjögren, Joakim Nyberg, Mats O. Magnusson, Hans Lennernäs, Andrew Hooker and Ulf Bredberg
      Drug Metabolism and Disposition May 2011, 39 (5) 858-863; DOI: https://doi.org/10.1124/dmd.110.037309

  6. Li, Shuijun

    1. Contribution of Carboxylesterase in Hamster to the Intestinal First-Pass Loss and Low Bioavailability of Ethyl Piperate, an Effective Lipid-Lowering Drug Candidate
      Youli Lu, Narisu Bao, Gereltu Borjihan, Yanling Ma, Miaomiao Hu, Chen Yu, Shuijun Li, Jingying Jia, Ding Yang and Yiping Wang
      Drug Metabolism and Disposition May 2011, 39 (5) 796-802; DOI: https://doi.org/10.1124/dmd.110.037614

  7. Lindh, Jonatan D.

    1. Seasonal Variation in Blood Drug Concentrations and a Potential Relationship to Vitamin D
      Jonatan D. Lindh, Marine L. Andersson, Erik Eliasson and Linda Björkhem-Bergman
      Drug Metabolism and Disposition May 2011, 39 (5) 933-937; DOI: https://doi.org/10.1124/dmd.111.038125

  8. Liu, Duan

    1. Evaluation of the Effects of 20 Nonsynonymous Single Nucleotide Polymorphisms of CYP2C19 on S-Mephenytoin 4′-Hydroxylation and Omeprazole 5′-Hydroxylation
      Huijuan Wang, Nianzhen An, Hao Wang, Yiwen Gao, Duan Liu, Ting Bian, Juanli Zhu and Chao Chen
      Drug Metabolism and Disposition May 2011, 39 (5) 830-837; DOI: https://doi.org/10.1124/dmd.110.037549

  9. Locuson, Charles W.

    1. Pharmacokinetic Interaction of the Antiparasitic Agents Ivermectin and Spinosad in Dogs
      Stewart T. Dunn, Laura Hedges, Kathleen E. Sampson, Yurong Lai, Sean Mahabir, Larissa Balogh and Charles W. Locuson
      Drug Metabolism and Disposition May 2011, 39 (5) 789-795; DOI: https://doi.org/10.1124/dmd.110.034827

  10. Lu, Youli

    1. Contribution of Carboxylesterase in Hamster to the Intestinal First-Pass Loss and Low Bioavailability of Ethyl Piperate, an Effective Lipid-Lowering Drug Candidate
      Youli Lu, Narisu Bao, Gereltu Borjihan, Yanling Ma, Miaomiao Hu, Chen Yu, Shuijun Li, Jingying Jia, Ding Yang and Yiping Wang
      Drug Metabolism and Disposition May 2011, 39 (5) 796-802; DOI: https://doi.org/10.1124/dmd.110.037614

  11. Lundahl, Anna

    1. In Vivo Investigation in Pigs of Intestinal Absorption, Hepatobiliary Disposition, and Metabolism of the 5α-Reductase Inhibitor Finasteride and the Effects of Coadministered Ketoconazole
      Anna Lundahl, Mikael Hedeland, Ulf Bondesson and Hans Lennernäs
      Drug Metabolism and Disposition May 2011, 39 (5) 847-857; DOI: https://doi.org/10.1124/dmd.110.035311

M

  1. Ma, Bennett

    1. Novel Cytochrome P450-Mediated Ring Opening of the 1,3,4-Oxadiazole in Setileuton, a 5-Lipoxygenase Inhibitor
      Cheri M. Maciolek, Bennett Ma, Karsten Menzel, Sebastien Laliberte, Kevin Bateman, Paul Krolikowski and Christoper R. Gibson
      Drug Metabolism and Disposition May 2011, 39 (5) 763-770; DOI: https://doi.org/10.1124/dmd.110.037366

  2. Ma, Yanling

    1. Contribution of Carboxylesterase in Hamster to the Intestinal First-Pass Loss and Low Bioavailability of Ethyl Piperate, an Effective Lipid-Lowering Drug Candidate
      Youli Lu, Narisu Bao, Gereltu Borjihan, Yanling Ma, Miaomiao Hu, Chen Yu, Shuijun Li, Jingying Jia, Ding Yang and Yiping Wang
      Drug Metabolism and Disposition May 2011, 39 (5) 796-802; DOI: https://doi.org/10.1124/dmd.110.037614

  3. Maciolek, Cheri M.

    1. Novel Cytochrome P450-Mediated Ring Opening of the 1,3,4-Oxadiazole in Setileuton, a 5-Lipoxygenase Inhibitor
      Cheri M. Maciolek, Bennett Ma, Karsten Menzel, Sebastien Laliberte, Kevin Bateman, Paul Krolikowski and Christoper R. Gibson
      Drug Metabolism and Disposition May 2011, 39 (5) 763-770; DOI: https://doi.org/10.1124/dmd.110.037366

  4. Magnusson, Mats O.

    1. Optimal Experimental Design for Assessment of Enzyme Kinetics in a Drug Discovery Screening Environment
      Erik Sjögren, Joakim Nyberg, Mats O. Magnusson, Hans Lennernäs, Andrew Hooker and Ulf Bredberg
      Drug Metabolism and Disposition May 2011, 39 (5) 858-863; DOI: https://doi.org/10.1124/dmd.110.037309

  5. Mahabir, Sean

    1. Pharmacokinetic Interaction of the Antiparasitic Agents Ivermectin and Spinosad in Dogs
      Stewart T. Dunn, Laura Hedges, Kathleen E. Sampson, Yurong Lai, Sean Mahabir, Larissa Balogh and Charles W. Locuson
      Drug Metabolism and Disposition May 2011, 39 (5) 789-795; DOI: https://doi.org/10.1124/dmd.110.034827

  6. Masson, Eric

    1. Metabolism and Disposition of [14C]Brivanib Alaninate after Oral Administration to Rats, Monkeys, and Humans
      Jiachang Gong, Jinping Gan, Janet Caceres-Cortes, Lisa J. Christopher, Vinod Arora, Eric Masson, Daphne Williams, Janice Pursley, Alban Allentoff, Michael Lago, Scott B. Tran and Ramaswamy A. Iyer
      Drug Metabolism and Disposition May 2011, 39 (5) 891-903; DOI: https://doi.org/10.1124/dmd.110.037341

  7. Mattiuz, Edward

    1. Metabolism of LY654322, a Growth Hormone Secretagogue, to an Unusual Diimidazopyridine Metabolite
      Anthony G. Borel, Timothy M. Jones, Robert J. Barbuch, David A. Jackson, Palaniappan Kulanthaivel, Edward Mattiuz, Valentine J. Klimkowski, William J. Wheeler and Gregory A. Rener
      Drug Metabolism and Disposition May 2011, 39 (5) 740-749; DOI: https://doi.org/10.1124/dmd.110.037598

  8. Menzel, Karsten

    1. Novel Cytochrome P450-Mediated Ring Opening of the 1,3,4-Oxadiazole in Setileuton, a 5-Lipoxygenase Inhibitor
      Cheri M. Maciolek, Bennett Ma, Karsten Menzel, Sebastien Laliberte, Kevin Bateman, Paul Krolikowski and Christoper R. Gibson
      Drug Metabolism and Disposition May 2011, 39 (5) 763-770; DOI: https://doi.org/10.1124/dmd.110.037366

  9. Miyagi, Shogo J.

    1. The Development of UDP-Glucuronosyltransferases 1A1 and 1A6 in the Pediatric Liver
      Shogo J. Miyagi and Abby C. Collier
      Drug Metabolism and Disposition May 2011, 39 (5) 912-919; DOI: https://doi.org/10.1124/dmd.110.037192

  10. Miyajima, Mari

    1. Organic Anion Transporter 3 Mediates the Efflux Transport of an Amphipathic Organic Anion, Dehydroepiandrosterone Sulfate, across the Blood-Brain Barrier in Mice
      Mari Miyajima, Hiroyuki Kusuhara, Miki Fujishima, Yasuhisa Adachi and Yuichi Sugiyama
      Drug Metabolism and Disposition May 2011, 39 (5) 814-819; DOI: https://doi.org/10.1124/dmd.110.036863

  11. Murata, Shinji

    1. Human Pharmacokinetic Prediction of UDP-Glucuronosyltransferase Substrates with an Animal Scale-Up Approach
      Tsuneo Deguchi, Nobuaki Watanabe, Atsushi Kurihara, Katsuhiro Igeta, Hidenori Ikenaga, Keiichi Fusegawa, Norio Suzuki, Shinji Murata, Masakazu Hirouchi, Yoshitake Furuta, Masaru Iwasaki, Osamu Okazaki and Takashi Izumi
      Drug Metabolism and Disposition May 2011, 39 (5) 820-829; DOI: https://doi.org/10.1124/dmd.110.037457

  12. Murayama, Norie

    1. Sorafenib and Sunitinib, Two Anticancer Drugs, Inhibit CYP3A4-Mediated and Activate CY3A5-Mediated Midazolam 1′-Hydroxylation
      Minako Sugiyama, Ken-ichi Fujita, Norie Murayama, Yuko Akiyama, Hiroshi Yamazaki and Yasutsuna Sasaki
      Drug Metabolism and Disposition May 2011, 39 (5) 757-762; DOI: https://doi.org/10.1124/dmd.110.037853

N

  1. Nakajima, Miki

    1. CYP2C9-Mediated Metabolic Activation of Losartan Detected by a Highly Sensitive Cell-Based Screening Assay
      Atsushi Iwamura, Tatsuki Fukami, Hiroko Hosomi, Miki Nakajima and Tsuyoshi Yokoi
      Drug Metabolism and Disposition May 2011, 39 (5) 838-846; DOI: https://doi.org/10.1124/dmd.110.037259

  2. Neuvonen, Pertti J.

    1. Reevaluation of the Microsomal Metabolism of Montelukast: Major Contribution by CYP2C8 at Clinically Relevant Concentrations
      Anne M. Filppula, Jouko Laitila, Pertti J. Neuvonen and Janne T. Backman
      Drug Metabolism and Disposition May 2011, 39 (5) 904-911; DOI: https://doi.org/10.1124/dmd.110.037689

  3. Nyberg, Joakim

    1. Optimal Experimental Design for Assessment of Enzyme Kinetics in a Drug Discovery Screening Environment
      Erik Sjögren, Joakim Nyberg, Mats O. Magnusson, Hans Lennernäs, Andrew Hooker and Ulf Bredberg
      Drug Metabolism and Disposition May 2011, 39 (5) 858-863; DOI: https://doi.org/10.1124/dmd.110.037309

O

  1. Okazaki, Osamu

    1. Human Pharmacokinetic Prediction of UDP-Glucuronosyltransferase Substrates with an Animal Scale-Up Approach
      Tsuneo Deguchi, Nobuaki Watanabe, Atsushi Kurihara, Katsuhiro Igeta, Hidenori Ikenaga, Keiichi Fusegawa, Norio Suzuki, Shinji Murata, Masakazu Hirouchi, Yoshitake Furuta, Masaru Iwasaki, Osamu Okazaki and Takashi Izumi
      Drug Metabolism and Disposition May 2011, 39 (5) 820-829; DOI: https://doi.org/10.1124/dmd.110.037457

  2. Onoda, Makoto

    1. Metabolism of the c-Fos/Activator Protein-1 Inhibitor T-5224 by Multiple Human UDP-Glucuronosyltransferase Isoforms
      Shinsuke Uchihashi, Hiroyuki Fukumoto, Makoto Onoda, Hiroyoshi Hayakawa, Shin-ichi Ikushiro and Toshiyuki Sakaki
      Drug Metabolism and Disposition May 2011, 39 (5) 803-813; DOI: https://doi.org/10.1124/dmd.110.037952

P

  1. Peters, Ron

    1. Identification of the Metabolites of the Antioxidant Flavonoid 7-Mono-O-(β-hydroxyethyl)-rutoside in Mice
      Hilde Jacobs, Ron Peters, Gertjan J. M. den Hartog, Wim J. F. van der Vijgh, Aalt Bast and Guido R. M. M. Haenen
      Drug Metabolism and Disposition May 2011, 39 (5) 750-756; DOI: https://doi.org/10.1124/dmd.110.036525

  2. Poller, Birk

    1. Differential Impact of P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) on Axitinib Brain Accumulation and Oral Plasma Pharmacokinetics
      Birk Poller, Dilek Iusuf, Rolf W. Sparidans, Els Wagenaar, Jos H. Beijnen and Alfred H. Schinkel
      Drug Metabolism and Disposition May 2011, 39 (5) 729-735; DOI: https://doi.org/10.1124/dmd.110.037317

  3. Polli, James

    1. In Vivo Magnetic Resonance Imaging to Detect Biliary Excretion of 19F-Labeled Drug in Mice
      Jean-Pierre Raufman, Su Xu, Kunrong Cheng, Sandeep Khurana, Diana Johnson, Changxing Shao, Maureen A. Kane, Da Shi, Rao Gullapalli and James Polli
      Drug Metabolism and Disposition May 2011, 39 (5) 736-739; DOI: https://doi.org/10.1124/dmd.110.037358

  4. Pursley, Janice

    1. Metabolism and Disposition of [14C]Brivanib Alaninate after Oral Administration to Rats, Monkeys, and Humans
      Jiachang Gong, Jinping Gan, Janet Caceres-Cortes, Lisa J. Christopher, Vinod Arora, Eric Masson, Daphne Williams, Janice Pursley, Alban Allentoff, Michael Lago, Scott B. Tran and Ramaswamy A. Iyer
      Drug Metabolism and Disposition May 2011, 39 (5) 891-903; DOI: https://doi.org/10.1124/dmd.110.037341

R

  1. Raufman, Jean-Pierre

    1. In Vivo Magnetic Resonance Imaging to Detect Biliary Excretion of 19F-Labeled Drug in Mice
      Jean-Pierre Raufman, Su Xu, Kunrong Cheng, Sandeep Khurana, Diana Johnson, Changxing Shao, Maureen A. Kane, Da Shi, Rao Gullapalli and James Polli
      Drug Metabolism and Disposition May 2011, 39 (5) 736-739; DOI: https://doi.org/10.1124/dmd.110.037358

  2. Rener, Gregory A.

    1. Metabolism of LY654322, a Growth Hormone Secretagogue, to an Unusual Diimidazopyridine Metabolite
      Anthony G. Borel, Timothy M. Jones, Robert J. Barbuch, David A. Jackson, Palaniappan Kulanthaivel, Edward Mattiuz, Valentine J. Klimkowski, William J. Wheeler and Gregory A. Rener
      Drug Metabolism and Disposition May 2011, 39 (5) 740-749; DOI: https://doi.org/10.1124/dmd.110.037598

  3. Roth, Megan

    1. Interactions of Green Tea Catechins with Organic Anion-Transporting Polypeptides
      Megan Roth, Barbara N. Timmermann and Bruno Hagenbuch
      Drug Metabolism and Disposition May 2011, 39 (5) 920-926; DOI: https://doi.org/10.1124/dmd.110.036640

S

  1. Sakaki, Toshiyuki

    1. Metabolism of the c-Fos/Activator Protein-1 Inhibitor T-5224 by Multiple Human UDP-Glucuronosyltransferase Isoforms
      Shinsuke Uchihashi, Hiroyuki Fukumoto, Makoto Onoda, Hiroyoshi Hayakawa, Shin-ichi Ikushiro and Toshiyuki Sakaki
      Drug Metabolism and Disposition May 2011, 39 (5) 803-813; DOI: https://doi.org/10.1124/dmd.110.037952

  2. Sampson, Kathleen E.

    1. Pharmacokinetic Interaction of the Antiparasitic Agents Ivermectin and Spinosad in Dogs
      Stewart T. Dunn, Laura Hedges, Kathleen E. Sampson, Yurong Lai, Sean Mahabir, Larissa Balogh and Charles W. Locuson
      Drug Metabolism and Disposition May 2011, 39 (5) 789-795; DOI: https://doi.org/10.1124/dmd.110.034827

  3. Sasaki, Yasutsuna

    1. Sorafenib and Sunitinib, Two Anticancer Drugs, Inhibit CYP3A4-Mediated and Activate CY3A5-Mediated Midazolam 1′-Hydroxylation
      Minako Sugiyama, Ken-ichi Fujita, Norie Murayama, Yuko Akiyama, Hiroshi Yamazaki and Yasutsuna Sasaki
      Drug Metabolism and Disposition May 2011, 39 (5) 757-762; DOI: https://doi.org/10.1124/dmd.110.037853

  4. Schinkel, Alfred H.

    1. Differential Impact of P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) on Axitinib Brain Accumulation and Oral Plasma Pharmacokinetics
      Birk Poller, Dilek Iusuf, Rolf W. Sparidans, Els Wagenaar, Jos H. Beijnen and Alfred H. Schinkel
      Drug Metabolism and Disposition May 2011, 39 (5) 729-735; DOI: https://doi.org/10.1124/dmd.110.037317

  5. Shao, Changxing

    1. In Vivo Magnetic Resonance Imaging to Detect Biliary Excretion of 19F-Labeled Drug in Mice
      Jean-Pierre Raufman, Su Xu, Kunrong Cheng, Sandeep Khurana, Diana Johnson, Changxing Shao, Maureen A. Kane, Da Shi, Rao Gullapalli and James Polli
      Drug Metabolism and Disposition May 2011, 39 (5) 736-739; DOI: https://doi.org/10.1124/dmd.110.037358

  6. Shi, Da

    1. In Vivo Magnetic Resonance Imaging to Detect Biliary Excretion of 19F-Labeled Drug in Mice
      Jean-Pierre Raufman, Su Xu, Kunrong Cheng, Sandeep Khurana, Diana Johnson, Changxing Shao, Maureen A. Kane, Da Shi, Rao Gullapalli and James Polli
      Drug Metabolism and Disposition May 2011, 39 (5) 736-739; DOI: https://doi.org/10.1124/dmd.110.037358

  7. Sjögren, Erik

    1. Optimal Experimental Design for Assessment of Enzyme Kinetics in a Drug Discovery Screening Environment
      Erik Sjögren, Joakim Nyberg, Mats O. Magnusson, Hans Lennernäs, Andrew Hooker and Ulf Bredberg
      Drug Metabolism and Disposition May 2011, 39 (5) 858-863; DOI: https://doi.org/10.1124/dmd.110.037309

  8. Snider, Natasha T.

    1. Anandamide Oxidation by Wild-Type and Polymorphically Expressed CYP2B6 and CYP2D6
      Chitra Sridar, Natasha T. Snider and Paul F. Hollenberg
      Drug Metabolism and Disposition May 2011, 39 (5) 782-788; DOI: https://doi.org/10.1124/dmd.110.036707

  9. Sparidans, Rolf W.

    1. Differential Impact of P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) on Axitinib Brain Accumulation and Oral Plasma Pharmacokinetics
      Birk Poller, Dilek Iusuf, Rolf W. Sparidans, Els Wagenaar, Jos H. Beijnen and Alfred H. Schinkel
      Drug Metabolism and Disposition May 2011, 39 (5) 729-735; DOI: https://doi.org/10.1124/dmd.110.037317

  10. Sridar, Chitra

    1. Anandamide Oxidation by Wild-Type and Polymorphically Expressed CYP2B6 and CYP2D6
      Chitra Sridar, Natasha T. Snider and Paul F. Hollenberg
      Drug Metabolism and Disposition May 2011, 39 (5) 782-788; DOI: https://doi.org/10.1124/dmd.110.036707

  11. Stingl, Julia C.

    1. Effect of the CYP2C8 Genotype on the Pharmacokinetics and Pharmacodynamics of Repaglinide
      Dorota Tomalik-Scharte, Uwe Fuhr, Martin Hellmich, Dorothee Frank, Oxana Doroshyenko, Alexander Jetter and Julia C. Stingl
      Drug Metabolism and Disposition May 2011, 39 (5) 927-932; DOI: https://doi.org/10.1124/dmd.110.036921

  12. Sugamori, Kim S.

    1. Liver-Selective Expression of Human Arylamine N-Acetyltransferase NAT2 in Transgenic Mice
      Kim S. Sugamori, Debbie Brenneman and Denis M. Grant
      Drug Metabolism and Disposition May 2011, 39 (5) 882-890; DOI: https://doi.org/10.1124/dmd.111.038216

  13. Sugiyama, Minako

    1. Sorafenib and Sunitinib, Two Anticancer Drugs, Inhibit CYP3A4-Mediated and Activate CY3A5-Mediated Midazolam 1′-Hydroxylation
      Minako Sugiyama, Ken-ichi Fujita, Norie Murayama, Yuko Akiyama, Hiroshi Yamazaki and Yasutsuna Sasaki
      Drug Metabolism and Disposition May 2011, 39 (5) 757-762; DOI: https://doi.org/10.1124/dmd.110.037853

  14. Sugiyama, Yuichi

    1. Organic Anion Transporter 3 Mediates the Efflux Transport of an Amphipathic Organic Anion, Dehydroepiandrosterone Sulfate, across the Blood-Brain Barrier in Mice
      Mari Miyajima, Hiroyuki Kusuhara, Miki Fujishima, Yasuhisa Adachi and Yuichi Sugiyama
      Drug Metabolism and Disposition May 2011, 39 (5) 814-819; DOI: https://doi.org/10.1124/dmd.110.036863

  15. Suzuki, Norio

    1. Human Pharmacokinetic Prediction of UDP-Glucuronosyltransferase Substrates with an Animal Scale-Up Approach
      Tsuneo Deguchi, Nobuaki Watanabe, Atsushi Kurihara, Katsuhiro Igeta, Hidenori Ikenaga, Keiichi Fusegawa, Norio Suzuki, Shinji Murata, Masakazu Hirouchi, Yoshitake Furuta, Masaru Iwasaki, Osamu Okazaki and Takashi Izumi
      Drug Metabolism and Disposition May 2011, 39 (5) 820-829; DOI: https://doi.org/10.1124/dmd.110.037457

T

  1. Thakur, Ashish

    1. Influence of Drug Solubility and Lipophilicity on Transscleral Retinal Delivery of Six Corticosteroids
      Ashish Thakur, Rajendra S. Kadam and Uday B. Kompella
      Drug Metabolism and Disposition May 2011, 39 (5) 771-781; DOI: https://doi.org/10.1124/dmd.110.037408

  2. Timmermann, Barbara N.

    1. Interactions of Green Tea Catechins with Organic Anion-Transporting Polypeptides
      Megan Roth, Barbara N. Timmermann and Bruno Hagenbuch
      Drug Metabolism and Disposition May 2011, 39 (5) 920-926; DOI: https://doi.org/10.1124/dmd.110.036640

  3. Tomalik-Scharte, Dorota

    1. Effect of the CYP2C8 Genotype on the Pharmacokinetics and Pharmacodynamics of Repaglinide
      Dorota Tomalik-Scharte, Uwe Fuhr, Martin Hellmich, Dorothee Frank, Oxana Doroshyenko, Alexander Jetter and Julia C. Stingl
      Drug Metabolism and Disposition May 2011, 39 (5) 927-932; DOI: https://doi.org/10.1124/dmd.110.036921

  4. Tran, Scott B.

    1. Metabolism and Disposition of [14C]Brivanib Alaninate after Oral Administration to Rats, Monkeys, and Humans
      Jiachang Gong, Jinping Gan, Janet Caceres-Cortes, Lisa J. Christopher, Vinod Arora, Eric Masson, Daphne Williams, Janice Pursley, Alban Allentoff, Michael Lago, Scott B. Tran and Ramaswamy A. Iyer
      Drug Metabolism and Disposition May 2011, 39 (5) 891-903; DOI: https://doi.org/10.1124/dmd.110.037341

U

  1. Uchihashi, Shinsuke

    1. Metabolism of the c-Fos/Activator Protein-1 Inhibitor T-5224 by Multiple Human UDP-Glucuronosyltransferase Isoforms
      Shinsuke Uchihashi, Hiroyuki Fukumoto, Makoto Onoda, Hiroyoshi Hayakawa, Shin-ichi Ikushiro and Toshiyuki Sakaki
      Drug Metabolism and Disposition May 2011, 39 (5) 803-813; DOI: https://doi.org/10.1124/dmd.110.037952

V

  1. Vallejo, Jesus G.

    1. Differential Role of Toll-Interleukin 1 Receptor Domain-Containing Adaptor Protein in Toll-Like Receptor 2-Mediated Regulation of Gene Expression of Hepatic Cytokines and Drug-Metabolizing Enzymes
      Romi Ghose, Tao Guo, Jesus G. Vallejo and Adarsh Gandhi
      Drug Metabolism and Disposition May 2011, 39 (5) 874-881; DOI: https://doi.org/10.1124/dmd.110.037382

  2. van der Vijgh, Wim J. F.

    1. Identification of the Metabolites of the Antioxidant Flavonoid 7-Mono-O-(β-hydroxyethyl)-rutoside in Mice
      Hilde Jacobs, Ron Peters, Gertjan J. M. den Hartog, Wim J. F. van der Vijgh, Aalt Bast and Guido R. M. M. Haenen
      Drug Metabolism and Disposition May 2011, 39 (5) 750-756; DOI: https://doi.org/10.1124/dmd.110.036525

W

  1. Wagenaar, Els

    1. Differential Impact of P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) on Axitinib Brain Accumulation and Oral Plasma Pharmacokinetics
      Birk Poller, Dilek Iusuf, Rolf W. Sparidans, Els Wagenaar, Jos H. Beijnen and Alfred H. Schinkel
      Drug Metabolism and Disposition May 2011, 39 (5) 729-735; DOI: https://doi.org/10.1124/dmd.110.037317

  2. Wang, Hao

    1. Evaluation of the Effects of 20 Nonsynonymous Single Nucleotide Polymorphisms of CYP2C19 on S-Mephenytoin 4′-Hydroxylation and Omeprazole 5′-Hydroxylation
      Huijuan Wang, Nianzhen An, Hao Wang, Yiwen Gao, Duan Liu, Ting Bian, Juanli Zhu and Chao Chen
      Drug Metabolism and Disposition May 2011, 39 (5) 830-837; DOI: https://doi.org/10.1124/dmd.110.037549

  3. Wang, Huijuan

    1. Evaluation of the Effects of 20 Nonsynonymous Single Nucleotide Polymorphisms of CYP2C19 on S-Mephenytoin 4′-Hydroxylation and Omeprazole 5′-Hydroxylation
      Huijuan Wang, Nianzhen An, Hao Wang, Yiwen Gao, Duan Liu, Ting Bian, Juanli Zhu and Chao Chen
      Drug Metabolism and Disposition May 2011, 39 (5) 830-837; DOI: https://doi.org/10.1124/dmd.110.037549

  4. Wang, Yiping

    1. Contribution of Carboxylesterase in Hamster to the Intestinal First-Pass Loss and Low Bioavailability of Ethyl Piperate, an Effective Lipid-Lowering Drug Candidate
      Youli Lu, Narisu Bao, Gereltu Borjihan, Yanling Ma, Miaomiao Hu, Chen Yu, Shuijun Li, Jingying Jia, Ding Yang and Yiping Wang
      Drug Metabolism and Disposition May 2011, 39 (5) 796-802; DOI: https://doi.org/10.1124/dmd.110.037614

  5. Watanabe, Nobuaki

    1. Human Pharmacokinetic Prediction of UDP-Glucuronosyltransferase Substrates with an Animal Scale-Up Approach
      Tsuneo Deguchi, Nobuaki Watanabe, Atsushi Kurihara, Katsuhiro Igeta, Hidenori Ikenaga, Keiichi Fusegawa, Norio Suzuki, Shinji Murata, Masakazu Hirouchi, Yoshitake Furuta, Masaru Iwasaki, Osamu Okazaki and Takashi Izumi
      Drug Metabolism and Disposition May 2011, 39 (5) 820-829; DOI: https://doi.org/10.1124/dmd.110.037457

  6. Wheeler, William J.

    1. Metabolism of LY654322, a Growth Hormone Secretagogue, to an Unusual Diimidazopyridine Metabolite
      Anthony G. Borel, Timothy M. Jones, Robert J. Barbuch, David A. Jackson, Palaniappan Kulanthaivel, Edward Mattiuz, Valentine J. Klimkowski, William J. Wheeler and Gregory A. Rener
      Drug Metabolism and Disposition May 2011, 39 (5) 740-749; DOI: https://doi.org/10.1124/dmd.110.037598

  7. Williams, Daphne

    1. Metabolism and Disposition of [14C]Brivanib Alaninate after Oral Administration to Rats, Monkeys, and Humans
      Jiachang Gong, Jinping Gan, Janet Caceres-Cortes, Lisa J. Christopher, Vinod Arora, Eric Masson, Daphne Williams, Janice Pursley, Alban Allentoff, Michael Lago, Scott B. Tran and Ramaswamy A. Iyer
      Drug Metabolism and Disposition May 2011, 39 (5) 891-903; DOI: https://doi.org/10.1124/dmd.110.037341

X

  1. Xu, Su

    1. In Vivo Magnetic Resonance Imaging to Detect Biliary Excretion of 19F-Labeled Drug in Mice
      Jean-Pierre Raufman, Su Xu, Kunrong Cheng, Sandeep Khurana, Diana Johnson, Changxing Shao, Maureen A. Kane, Da Shi, Rao Gullapalli and James Polli
      Drug Metabolism and Disposition May 2011, 39 (5) 736-739; DOI: https://doi.org/10.1124/dmd.110.037358

Y

  1. Yamazaki, Hiroshi

    1. Sorafenib and Sunitinib, Two Anticancer Drugs, Inhibit CYP3A4-Mediated and Activate CY3A5-Mediated Midazolam 1′-Hydroxylation
      Minako Sugiyama, Ken-ichi Fujita, Norie Murayama, Yuko Akiyama, Hiroshi Yamazaki and Yasutsuna Sasaki
      Drug Metabolism and Disposition May 2011, 39 (5) 757-762; DOI: https://doi.org/10.1124/dmd.110.037853

  2. Yang, Ding

    1. Contribution of Carboxylesterase in Hamster to the Intestinal First-Pass Loss and Low Bioavailability of Ethyl Piperate, an Effective Lipid-Lowering Drug Candidate
      Youli Lu, Narisu Bao, Gereltu Borjihan, Yanling Ma, Miaomiao Hu, Chen Yu, Shuijun Li, Jingying Jia, Ding Yang and Yiping Wang
      Drug Metabolism and Disposition May 2011, 39 (5) 796-802; DOI: https://doi.org/10.1124/dmd.110.037614

  3. Yokoi, Tsuyoshi

    1. CYP2C9-Mediated Metabolic Activation of Losartan Detected by a Highly Sensitive Cell-Based Screening Assay
      Atsushi Iwamura, Tatsuki Fukami, Hiroko Hosomi, Miki Nakajima and Tsuyoshi Yokoi
      Drug Metabolism and Disposition May 2011, 39 (5) 838-846; DOI: https://doi.org/10.1124/dmd.110.037259

  4. Yu, Chen

    1. Contribution of Carboxylesterase in Hamster to the Intestinal First-Pass Loss and Low Bioavailability of Ethyl Piperate, an Effective Lipid-Lowering Drug Candidate
      Youli Lu, Narisu Bao, Gereltu Borjihan, Yanling Ma, Miaomiao Hu, Chen Yu, Shuijun Li, Jingying Jia, Ding Yang and Yiping Wang
      Drug Metabolism and Disposition May 2011, 39 (5) 796-802; DOI: https://doi.org/10.1124/dmd.110.037614

Z

  1. Zhu, Juanli

    1. Evaluation of the Effects of 20 Nonsynonymous Single Nucleotide Polymorphisms of CYP2C19 on S-Mephenytoin 4′-Hydroxylation and Omeprazole 5′-Hydroxylation
      Huijuan Wang, Nianzhen An, Hao Wang, Yiwen Gao, Duan Liu, Ting Bian, Juanli Zhu and Chao Chen
      Drug Metabolism and Disposition May 2011, 39 (5) 830-837; DOI: https://doi.org/10.1124/dmd.110.037549
Back to top

In this issue